Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR5A1 | Q13285 | 1/20 | 0.53 |
| ▸ | TP53 | P04637 | 2/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | PLA2G4B | P0C869 | 6/20 | 0.50 |
| ▸ | RARB | P10826 | 3/20 | 0.48 |
| ▸ | LTA4H | P09960 | 1/20 | 0.46 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL995052 | 1.00 | NR5A1 (0.53) | NR5A1TP53TSHRPLA2G4BRARB | |
| SCHEMBL997826 | 0.81 | ESR1 (0.49) | TP53RARBLMNAHSD17B10 | |
| SCHEMBL998130 | 0.81 | ESR1 (0.49) | TP53RARBLMNAHSD17B10 | |
| SCHEMBL2948040 | 0.78 | ALDH1A1 (0.42) | NPC1LMNAMAPTALOX15RAB9A | |
| SCHEMBL996014 | 0.78 | FDPS (0.43) | TP53TSHRRARBGAA | |
| SCHEMBL8936597 | 0.75 | NR5A1 (0.79) | NR5A1TP53TSHRPLA2G4BRARB | |
| SCHEMBL5473083 | 0.75 | NR5A1 (0.79) | NR5A1TP53TSHRPLA2G4BRARB | |
| SCHEMBL10943900 | 0.75 | NR5A1 (0.79) | NR5A1TP53TSHRPLA2G4BRARB | |
| SCHEMBL2829024 | 0.75 | NR5A1 (0.79) | NR5A1TP53TSHRPLA2G4BRARB | |
| SCHEMBL28373061 | 0.75 | NR5A1 (0.79) | NR5A1TP53TSHRPLA2G4BRARB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9133211-B2 | Dithienobenzodithiophene semiconductive material and electronic device using the same | RICOH COMPANY, LTD. (JP) | 2015-09-15 | — | — | US | disclosed |
| EP-2457272-A1 | NOVEL ORGANIC SEMICONDUCTIVE MATERIAL AND ELECTRONIC DEVICE USING THE SAME | Ricoh Company, Ltd. (JP) | 2012-05-30 | — | — | EP | disclosed |
| US-20120119195-A1 | NOVEL ORGANIC SEMICONDUCTIVE MATERIAL AND ELECTRONIC DEVICE USING THE SAME | RICOH COMPANY, LTD. (JP) | 2012-05-17 | — | — | US | disclosed |
| WO-2011010710-A1 | NOVEL ORGANIC SEMICONDUCTIVE MATERIAL AND ELECTRONIC DEVICE USING THE SAME | RICOH COMPANY, LTD. (JP) | 2011-01-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120119195-A1 | NOVEL ORGANIC SEMICONDUCTIVE MATERIAL AND ELECTRONIC DEVICE USING THE SAME | RPS10, OR10J3, RPS20 | NR5A1 1545/4885TP53 4439/4885TSHR 2803/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.